Anzeige
+++>>> Schnelle Produktionsaufnahme?: Multi-Tenbagger-Potenzial direkt in Spanien? <<<+++
PLX PHARMA WKN: A2DMUN ISIN: US72942A1079 Kürzel: 1D5A Forum: Aktien Thema: Hauptdiskussion
0,0000 USD
±0,00 %±0,0000
30. Sep, 00:20:00 Uhr,
Nasdaq OTC
Kommentare 102
Summer.76,
13.05.2022 15:33 Uhr
0
https://www.globenewswire.com/news-release/2022/05/13/2442870/37097/en/PLx-Pharma-Inc-Reports-First-Quarter-2022-Results-and-Provides-Business-Update.html
Summer.76,
12.08.2022 13:00 Uhr
0
PLx Pharma Inc. Reports Second Quarter 2022 Results and Provides Business Update
https://www.globenewswire.com/news-release/2022/08/12/2497463/37097/en/PLx-Pharma-Inc-Reports-Second-Quarter-2022-Results-and-Provides-Business-Update.html
Summer.76,
11.03.2022 16:12 Uhr
0
https://www.biospace.com/article/releases/plx-pharma-inc-reports-fourth-quarter-and-full-year-2021-results-and-provides-business-update/?s=110
PLx Pharma Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
Momentum Building for Novel Vazalore® Liquid-Filled Aspirin Capsules
• Total Net Sales of $8.2 Million in Last Five Months of 2021
• Net Sales of $1.6 Million in the Fourth Quarter 2021, Reflecting Timing of Trade Re-Orders Following Strong Initial Sales Distribution of VAZALORE in the Third Quarter 2021
• Key Performance Measures Are Positive and Trending Higher; Company on Track and Well-Positioned to Grow Sales Substantially in 2022
• GAAP Net Loss of ($0.73) Per Diluted Share in Fourth Quarter 2021; Adjusted Non-GAAP Net Loss Per Diluted Share of ($0.73)
• Cash & Cash Equivalent Balance of $69.4 Million at Year-End 2021
nionus,
07.02.2022 7:25 Uhr
2
https://youtu.be/O_OCb5owR7g
TV Werbespot der aktuell in den USA läuft.
nionus,
07.12.2021 19:03 Uhr
0
https://seekingalpha.com/news/3777793-plx-pharma-gains-after-raymond-james-upgraded-on-valuation
nionus,
15.11.2021 19:28 Uhr
0
https://zolmax.com/investing/plx-pharma-inc-nasdaqplxp-shares-purchased-by-vanguard-group-inc/6508739.html
Summer.76,
12.11.2021 13:15 Uhr
0
PLx Pharma EPS beats by $0.09, beats on revenue
https://seekingalpha.com/news/3769940-plx-pharma-eps-beats-0_09-beats-on-revenue?utm_source=webull.com&utm_medium=referral
• PLx Pharma (NASDAQ:PLXP): Q3 Non-GAAP EPS of -$0.37 beats by $0.09; GAAP EPS of -$0.80 misses by $0.34.
• Revenue of $6.6M beats by $2.5M.
Summer.76,
12.11.2021 13:12 Uhr
0
PLx Pharma Inc. Reports Third Quarter 2021 Results and Provides Business Update
https://finance.yahoo.com/news/plx-pharma-inc-reports-third-115000911.html
-- Results demonstrate strong execution of initial phase of VAZALORE commercial launch, including shipments to 30,000+ stores nationwide and e-commerce sites --
-- Reported net revenue of $6.6 million in third quarter 2021 reflecting initial sales of VAZALORE --
-- Third quarter 2021 net loss was ($0.80) per share and adjusted non-GAAP net loss per share of ($0.37) --
-- Early feedback received from consumers and healthcare professionals is very positive -–
Summer.76,
04.11.2021 17:12 Uhr
0
PLx Pharma Inc. Announces New Scientific Data Available Evaluating the Pharmacologic Profile of FDA-Approved VAZALORE 81 mg Liquid-Filled Aspirin Capsules
https://finance.yahoo.com/news/plx-pharma-inc-announces-scientific-135000021.html
-- VAZALORE 81 mg shows fast bioavailability, absorption, and platelet inhibition --
-- VAZALORE 81 mg has pharmacokinetic and pharmacodynamic profiles consistent with
VAZALORE 325 mg --
...
nionus,
01.11.2021 19:40 Uhr
0
https://www.analystratings.com/articles/jmp-securities-remains-a-buy-on-plx-pharma-plxp/
Summer.76,
29.10.2021 15:11 Uhr
0
PLx Pharma Inc. Provides VAZALORE Launch Update
https://www.globenewswire.com/news-release/2021/10/29/2323515/0/en/PLx-Pharma-Inc-Provides-VAZALORE-Launch-Update.html
-- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites --
-- Launch in line with expectations and exceptionally positive feedback from consumers and healthcare professionals received --
-- Third quarter 2021 earnings and business update conference call scheduled for November 12th --
...
nionus,
26.10.2021 22:22 Uhr
0
https://www.infrastructurene.ws/2021/10/26/ischemic-cerebral-stroke-market-2021-major-eminent-key-players-growing-with-tremendous-speed-touching-new-industry-heights-forecast-by-2027/
nionus,
14.10.2021 21:57 Uhr
0
https://ir.plxpharma.com/news-releases/news-release-details/plx-pharma-inc-issues-statement-recent-usptf-recommendations
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | Das neue Dax Prognose Forum | +0,43 % | |
| 2 | TESLA MOTORS Hauptdiskussion | -0,11 % | |
| 3 | Aktien und Saunaclub alla Luci | ||
| 4 | Jaguar Health für Investierte und Interessierte | +2,24 % | |
| 5 | Mainz Biomed | -5,07 % | |
| 6 | NVIDIA Hauptdiskussion | +3,13 % | |
| 7 | PAYPAL Hauptdiskussion | -2,38 % | |
| 8 | für alle, die es ehrlich meinen beim Traden. | ||
| 9 | Trading- und Aktien-Chat | ||
| 10 | Nantkwest / Immunitybio -> IBRX | -4,37 % | Alle Diskussionen |
Anzeige
![Über 2000 Sparpläne auf Aktien, ETFs und Fonds ab 0 Euro - Jetzt entdecken]()
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | TESLA MOTORS Hauptdiskussion | -0,02 % | |
| 2 | Jaguar Health für Investierte und Interessierte | +2,07 % | |
| 3 | Mainz Biomed | -5,07 % | |
| 4 | NVIDIA Hauptdiskussion | +3,01 % | |
| 5 | PAYPAL Hauptdiskussion | -2,42 % | |
| 6 | STANDARD LITHIUM Hauptdiskussion | -6,55 % | |
| 7 | Nantkwest / Immunitybio -> IBRX | -4,36 % | |
| 8 | Nikola Hauptforum | +4,07 % | |
| 9 | Annovis Bio | -9,35 % | |
| 10 | Canopy Hauptforum | -0,47 % | Alle Diskussionen |